Keyphrases
Immunogenic
66%
Genomic Analysis
66%
Non-pathogenic
66%
Mycobacterium
51%
Mycolicibacterium
33%
Cancer Treatment
33%
Bacillus Calmette
33%
Immunosuppressive Agents
33%
Mycobacterium Tuberculosis (M. tb)
23%
Rapid Growing
16%
Circular Chromosome
16%
CRISPR Loci
16%
ESX-1
16%
PacBio Reads
16%
Therapeutic Potential
16%
Spain
16%
Illumina Reads
16%
Human Samples
16%
Pathogenic Mycobacteria
16%
Species Variation
16%
Immunological Properties
16%
Mycobacterium Bovis BCG
16%
Pseudogene
16%
M. Bovis BCG
16%
Cell-to-cell
16%
T Cells
16%
Genome Content
16%
Prophage
16%
Phylogenetic Position
16%
Genome Composition
16%
Barcelona
16%
Mycobacterial Species
16%
Genomic Data
16%
Virulence Genes
16%
B-cell Antigens
16%
In Vivo Experiment
16%
High GC Content
16%
Pathogenic Potential
16%
Immunogenic Potential
16%
Environmental Samples
16%
Rapidly Growing Mycobacteria
16%
Infected Mice
13%
Severe Combined Immunodeficient Mice
6%
Immunomodulatory
6%
Biochemical Parameters
6%
Human Animals
6%
Alternative Therapy
6%
Galleria Mellonella Model
6%
Adverse Events
6%
Histopathological Changes
6%
Immunology and Microbiology
Mycobacteria
100%
Nontuberculous mycobacteria
33%
Bagg Albino Mouse
33%
Galleria mellonella
33%
Biological Product
33%
Bacterial Load
33%
Mycobacterium bovis
33%
SCID Mouse
33%
Colony Forming Unit S
33%
Immunotherapy
33%
Hemolymph
33%
Mycobacterium Bovis BCG
30%
Type Strain
30%
Prophage
15%
B Cell
15%
Pathogenic Potential
15%
Pseudogene
15%
Phylogeny
15%
Clustered Regularly Interspaced Short Palindromic Repeat
15%
T Cell
15%
Cell Antigen
15%
Cladistics
15%
Biochemistry, Genetics and Molecular Biology
Genomics
66%
Mycobacteria
58%
Mycobacterium Bovis BCG
25%
Type Strain
25%
GC-content
12%
Cladistics
12%
Pseudogene
12%
CRISPR
12%
Phylogeny
12%
B Cell
12%
Genetics
12%
T Cell
12%
Prophage
12%
